|
|
|||
|
||||
OverviewThe field of molecular genetics is undergoing an explosion, not only in its fundamental understanding of the genetic processes but also in the potential applications as research tools and therapeutic approaches to many disease areas. Mental disorders are no exception and it is likely that most new psychotropic drugs will be derived through molecular genetic approaches in the years to come. In spite of the importance of molecular genetics there is still an ignorance or misunderstanding of its uses among non-molecular scientists and clinicians. This is an examination of the place of molecular genetics in our understanding of the basic mechanisms of mental disorders and their role in highlighting new drug targets. Full Product DetailsAuthor: Mike Briley (Pierre Fabre Medicament, Castres Cedex, France) , Fridolin SulserPublisher: Taylor & Francis Ltd Imprint: Informa Healthcare Dimensions: Width: 18.70cm , Height: 17.80cm , Length: 23.50cm Weight: 0.939kg ISBN: 9781853179174ISBN 10: 1853179175 Pages: 354 Publication Date: 01 January 2000 Audience: College/higher education , Professional and scholarly , Undergraduate , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Out of Print Availability: Out of stock Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||